Biomanufacturing World Summit is the industry’s leading collection of manufacturing executives, thought leaders and innovators. We offer sponsors bespoke value added services tailored around your ability to pre-select prospects to meet with face-to-face.
If you are interested in learning more about sponsorship opportunities please call our Sponsorship Division at 416-829-6500 or email us at email@example.com.
Dassault Systèmes BIOVIA provides a scientific collaborative environment for advanced biological, chemical and materials experiences that help science- and process-driven companies develop higher quality products faster and more cost effectively. BIOVIA’s sophisticated enterprise system of modeling, simulation, laboratory and quality management allows customers to discover, design, deploy and deliver innovative sustainable and competitive products to consumers globally. Using BIOVIA technology organizations can access, organize, analyze and share scientific, quality and process data throughout the product lifecycle in regulated and non-regulated environments. BIOVIA integrates key components of a corporate quality strategy connecting and automating quality and compliance processes and advances Quality to enterprise wide Business Excellence in a sustainable manner. BIOVIA solutions are helping more than 2,000 companies globally in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries to enhance innovation, increase productivity, improve quality and compliance, reduce costs and accelerate time to market.
Sight Machine enables companies to gain real-time visibility and actionable insights for every part, machine, line, and plant throughout a manufacturing enterprise. Our analytics platform enables manufacturers to use all of their data—no matter where or in what format it’s created. We do this with an automated and systematic data intake process that acquires, refines, and contextualizes data, creating a digital twin of each part and process.
Althea is a fully integrated, contract development and manufacturing organization providing clinical and commercial product development services. Althea offers cGMP drug product filling in both vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA. In conjunction with these manufacturing operations, Althea offers comprehensive development services including: upstream and downstream process development, analytical development, lyophilization cycle, complex formulation, product release and ICH-compliant stability testing. In addition Althea offers a proprietary formulation technology platform, Crystalomics® and an innovative recombinant protein expression technology called Corynex® technology. Althea is the manufacturing partner that delivers the relentless dedication and support our clients need.
Bio-G is solely focused on one thing: delivering the highest quality modeling and scheduling software solutions to bio manufacturing companies. Our clients consistently achieve high return on project investment, verifiable increases in capacity and productivity, and measurable cost savings.
Headquartered in Berkeley, California, Bioproduction Group (Bio-G) is a privately held company specializing in real-time modeling systems. Bio-G has modeled more than 35% of global biomanufacturing capacity and our clients include small developmental companies as well as large clinical, commercial, and CMO manufacturers with sites ranging in size from small perfusion fed vessels up to 200K liters of capacity. These sites use a variety of processes including batch, fed batch, and continuous manufacturing, and utilize stainless steel, disposable, and hybrid technologies within their facilities.
Boehringer Ingelheim Biopharma Contract Manufacturing is represented by its brand Boehringer Ingelheim BioXcellence™. As a leading biopharmaceutical contract manufacturer with more than 35 years of experience it has brought more than 25 biopharmaceutical products to market. Boehringer Ingelheim BioXcellence™ offers tailor-made contract development and manufacturing services to the biopharmaceutical industry, providing the entire production technology chain from DNA to fill and finish under one roof at its facilities in Biberach (Germany), Vienna (Austria), Fremont (USA) and Shanghai (China).
Boehringer Ingelheim BioXcellence™ can secure product supply throughout the entire product lifecycle—transferring customer projects at any stage, delivering to almost any scale and thereby makes outsourcing easy.
The world leader in clean air technology and air filter production, Camfil is the largest supplier of filtration and terminal housings to the Life Sciences market. Products include ePTFE & glass media HEPAs, ULPA and molecular filters, Containment, Dust Collection and energy-efficient HVAC/ASHRAE products. Our LCC & CREO software are industry-leading programs.
We provide the tools to achieve sustainability, maintain high air quality and reduce airborne contaminants; all while lowering total cost of ownership.
Competitive Solutions, Inc., (CSI) is an international consulting/software firm serving fortune 500 companies around the globe since 1991. Our transformation platforms of Process Based Leadership® (PBL), PBL ScoreCard®, and Leadership GPS®, have been the solutions of choice in Pfizer, Novartis, Gilead, Roche, Genentech, GSK, Genzyme, and Alcon. CSI’s proven capabilities around Colleague Engagement, Robust and Sustainable Metrics that Matter, Visible and Personal Accountability Systems, and Communication Cadences that actually move the business forward, have made us the consulting partner of choice for the BIOTECH and Pharmaceutical industry. Our simple and sustainable turnkey solutions, leave nothing to chance and provide even the most advanced organization ideas and suggestions for simplification, continuous improvement and most importantly, bottom line impact.
EtQ is the leading Quality, EHS, Operational Risk and Compliance management software provider for identifying, mitigating and preventing high-risk events through integration, automation and collaboration. At the core of EtQ’s framework is a compliance management platform that enables organizations to implement best-in-class compliance processes configured to meet their existing processes, create new compliance processes and automate and control their compliance ecosystem. EtQ was founded in 1992 and has main offices located in the U.S. and Europe. To learn more about EtQ and its various product offerings, visit www.etq.com or blog.etq.com.
The Life Sciences business of GE Healthcare provides a wide range of bioprocessing products and services that enable the development and manufacture of high-quality biotherapeutics and vaccines. Using our knowledge and expertise, we support our customers in increasing speed to market, while avoiding unnecessary costs and improving quality and performance in drug manufacturing. As a provider of high-quality products, customized technical and commercial services, as well as design and construction of complete biomanufacturing solutions, we support the biopharmaceutical industry in making health visions a reality.
IDT Biologika is a specialized CDMO with expertise in research, development and manufacturing of viral vaccines and biologics for the global protection of human and animal health. IDT’s core expertise is the manufacturing of broad range vaccines, viral vectors and high value biologics and the provision of complex packaging solutions. At Dessau-Rosslau, Germany, IDT Biologika operates a full-fledged biopharmaceutical site with integrated leading edge development, production and quality control capacities for clinical development and commercial supply. The U.S. manufacturing facility in Rockville, Maryland, primarily provides development and manufacturing of vaccines and biologics for clinical phase I and II.
JHL Biotech is a biosimilars development firm that also co-develops innovative new biologics and performs contract services on behalf of select partners. JHL was founded in 2012 with support from premier partners such as KPCB, Milestone Capital, and Sequoia Capital. JHL is developing proposed biosimilars to bevacizumab, dornase alpha, rituximab, and trastuzumab. JHL owns and operates two manufacturing facilities based on single-use technologies, one at its headquarters in Hsinchu, Taiwan, and the second in Wuhan, China. In December 2016, JHL and Sanofi announced a strategic alliance for biologics co-development in China, with potential for international expansion.
Mettler-Toledo Process Analytics is a leader in process and pure water monitoring instrumentation used in pharmaceutical and biotech applications, offering systems for the measurement parameters of pH/ORP, dissolved oxygen, TOC, dissolved CO2, and conductivity. METTLER TOLEDO’s innovation continues with the introduction of the 7000RMS analyzer for on-line microbial monitoring.
Helping Clients Globally With Leadership Transitions in a Changing World
We have a proven leadership advisory approach to executive succession, leadership search and assessment, as well as organizational performance, culture, transformation and diversity. Our groundbreaking competency and assessment framework, Leadership Span, powers Russell Reynolds Associates’ leadership advisory work to help organizations achieve enhanced performance.
In today’s fast-paced and uncertain world, leaders face unprecedented challenges. They need to navigate through volatility while staying focused on strategy, performance and culture. To do this, they not only need to have a broad range of skills, they need to know when to use them. Our leadership advisory approach is designed to help organizations reduce the risk associated with selecting executives for leadership positions. Our unique framework, Leadership Span, helps increase the predictability of durable C-suite success.
At Russell Reynolds, we:
We do this by:
Werum IT Solutions is the world’s leading supplier of manufacturing execution systems (MES) and manufacturing IT solutions for the pharmaceutical and biopharmaceutical industries. Its PAS-X software product is run by the majority of the world’s top 30 pharmaceutical and biotech companies but also by many mid-sized manufacturers. Werum’s manufacturing IT solutions help pharma manufacturers to increase efficiency, improve productivity, and meet regulatory requirements. Founded in 1969, the company is headquartered in Lüneburg, Germany, and has many locations in Europe, America, and Asia.
Werum is part of Medipak Systems, the Pharma Systems business area of the international technology group Körber. Körber unites around 11,500 professionals in industry-leading companies worldwide, achieving annual earnings of 2.3 billion Euros.
Abzena is a life science group with headquarters in the UK, and chemistry and manufacturing sites in the US. Abzena’s complimentary services and technologies in chemistry, biology and manufacturing, are applied to the selection, development and manufacture of better biopharmaceuticals.
Abzena works with most of the top 20 biopharmaceutical companies and academic groups around the world, and has enabled many of them to progress products (ABZENA inside), through to clinical development.
Abzena’s teams at the Babraham Research Campus, Cambridge, UK, in San Diego, CA and Bristol, PA in the US are focused on developing better treatments for patients.
Since 1984 C2G has provided connectivity solutions and services to original equipment manufacturers in such diverse industries as medical/healthcare, contract manufacturing, gaming, hospitality and industrial. And now, as a brand of Legrand, C2G has access to an even broader portfolio of solutions, deep engineering and R&D resources, and the stability and strength that comes from being part of a global organization.
As the premier provider of OEM cabling and connectivity solutions, C2G is able to respond quickly to complex solution requirements and deliver an unparalleled level of service through:
-Rapid prototyping for fast proof-of-concept
-Custom cable solutions built to specification
-Quick quote response in one day on most projects
-Kitting, logistics, and warehousing support
Cobra Biologics is a leading international Contract Development and Manufacturing Organisation (CDMO) providing a comprehensive biologics and pharmaceuticals service offering. Our multi-functional and experienced project teams nurture customers’ products through to clinical and commercial manufacture. Cobra has three GMP approved facilities: in Sweden our Microbiota, DNA production and Fill Finish facility in Matfors and our monoclonal antibody (mAb)/ recombinant protein production facility in Södertälje, utilising Cobra’s maxXpress service using UCOE and CHO-S to enable rapid production of mAbs, recombinant proteins and biosimilars while ensuring efficient and stable expression and in the UK our Gene Therapy facility located in Keele for DNA and virus production.
We take pride in being a trusted manufacturer providing and delivering what we promise and helping our customers to develop medicines for the benefit of patients.
Compliance Architects LLC delivers high-value compliance, quality, and regulatory consulting services to companies directly regulated by the U.S. FDA and other global regulatory authorities. With capabilities ranging from quality systems implementations to audits, inspection readiness, enforcement remediation, and outsourced compliance services, Compliance Architects LLC has the experience, expertise, and delivery capability to significantly improve your company’s business outcomes.
Jack Garvey is CA’s founder and CEO, a chemical engineer and a practicing regulatory attorney, and has spent his entire career helping companies navigate the challenges at the intersections of science, engineering, business, and law.
The East Montgomery County Improvement District (EMCID), located northeast of Houston, is a political subdivision of the state of Texas responsible for promoting economic and community development. Our 500-acre industrial park — located just minutes from the Texas Medical Center, the Grand Parkway, Bush Intercontinental Airport and the Port of Houston — has sites available for business expansion opportunities. We offer extensive financial incentives, an available workforce, and an outstanding logistic infrastructure that are especially attractive for your expansion needs. Call 281-354-4419 for further details and development opportunities.
Ireland has a long tradition of pharmaceutical operational excellence and has been attracting manufacturing facilities from major Life Sciences companies for over fifty years. In the last ten years there has been a significant ramp-up in large molecule manufacturing. Over €10 billion in new investment has been committed in the last decade for new biotech manufacturing facilities in both drug substance and drug product. A deep pool of talented employees, an exemplary regulatory compliance record, strong government support for R&D, and zero-defect biopharmaceutical manufacturing excellence have driven this recent wave of investment in new biotech companies. The Irish Government is committed to continuing to invest in our education, research and broader ecosystem to ensure that Ireland remains the competitive location of choice. IDA Ireland is available to assist you at all stages of your decision making process and we also have a dedicated after care team to assist you with product implementation.
Meritech is the world’s only manufacturer of fully automated handwashing systems. Meritech’s unique 12-second hand wash technology is clinically backed to remove 99.98% of dangerous pathogens providing the only technology-based approach to employee hygiene. For cleanroom manufacturing areas, Meritech’s systems provide standardized and validated employee handwashing for contamination control; reducing bioburden and improving GMP gowning practices. Meritech also provides a unique line of footwear hygiene systems. Meritech systems are used in a wide variety of markets, including cleanroom manufacturing, food production and packaging, restaurants, theme parks, cruise lines, and more.
Nymi’s value proposition of “Always On Authentication” includes solutions that cater to a wide variety of use cases, ranging from multi-user, multi-terminal environments to broad-scope, company-wide authentication.
What is The Nymi Band:
The Nymi Band is the first solution that allows an enterprise to increase its security posture across physical and logical systems, while simultaneously improving convenience for users.
Pfanstiehl is a global leader in the manufacture of cGMP-produced, high purity, injectable grade excipients and bioprocessing solutions. The majority of leading biopharma firms trust Pfanstiehl to supply them with critical formulation components for their commercial manufacturing needs.
Biopharma manufacturing facilities in Singapore today manufacture 5 of the top 10 drugs globally. 8 of the top 10 pharmaceutical companies also have a regional presence in Singapore.
The Singapore Economic Development Board (EDB) undertakes investment promotion and industry development in industries such as the biopharma industry, to support companies keen to leverage Singapore as an operating base. Beyond facilitating investments, we also engage the existing base of companies to transform their operations and boost productivity, and to generate growth in adjacent and disruptive areas by growing new businesses out of Singapore.
Temptime is deeply committed to improving global public health. Founded in 1987, our scientists developed the first miniaturized technology to monitor temperature exposure of vials containing the oral polio vaccine. This device continues to be the only technology that meets the strict specifications of the world’s leading health organizations, including the World Health Organization, for distributing vaccines to developing countries.
Today, pharmaceutical corporations, biotechnology companies, specialty pharmacies, and hospitals are using our devices to help improve storing and handling thousands of medical products that improve and save lives. Since the medication you use is important and can be affected by extreme temperatures, it is our mission to monitor these products with 100 percent accuracy to ensure they have not been exposed to temperature events that could damage their effectiveness. We are dedicated to continually developing new technologies that will meaningfully improve global health for years to come.
Committed to innovation, product excellence, and customer success, Veeva has more than 475+ customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs.
The Veeva Vault Quality Suite of applications manages quality events from event origination to changing controlled content on a single cloud-base platform. Connecting quality processes with critical documentation, Vault QMS and Vault QualityDocs accelerates and streamlines event identification, correction, and change management. With greater end-to-end visibility, organizations respond to quality events faster and can easily provide a complete picture of quality management activities to regulators.
For more information, visit www.veeva.com/vault-quality
Emergent BioSolutions is dedicated to one simple mission — to protect and enhance life. We develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. We provide integrated contract development and manufacturing services for both drug substances and sterile injectable drug products. Our state-of-the-art single-use BDS facility enables turnkey upstream and downstream support for Eukaryotic and Viral expression at clinical and commercial scale. Emergent’s drug product facilities offer contract manufacturing services for the aseptic fill/finish of vials and syringes: liquid, lyophilized and viral products. Our facilities currently produce over 20 commercial products and a myriad of clinical candidates. Through our work, we envision protecting and enhancing 50 million lives with our products by the year 2025.